Authors' reply to the comment "High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa".
Overview
publication date
- November 27, 2020
published in
Research
keywords
- Hidradenitis Suppurativa
Identity
Scopus Document Identifier
- 85101689945
Digital Object Identifier (DOI)
- 10.1016/j.jaad.2020.11.041
PubMed ID
- 33253838
Additional Document Info
volume
- 84
issue
- 4